Tags : Hulio (adalimumab

Mylan Launches Hulio (adalimumab, biosimilar) in EU for Autoimmune Diseases

Shots: AbbVie’s Humira biosimilar, Hulio received EU approval in Sep 2018, reviewing CHMP approval which included biosimilarity data regarding analytical, functional, clinical and immunogenicity of Hulio with Humira The launch of Hulio post EU approval is available in all 28 EU member countries including Norway, Iceland and Liechtenstein. In July, 2018 Humira had brand sales […]Read More